Delivery Order SPE2DB20D9766-SPE2DB25FC1GD
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries a ceiling value of $5,021.26 and employs firm fixed-price pricing. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This firm fixed-price delivery order carries a ceiling value of $37.4K and represents a task order under the company's larger Indefinite Delivery Contract with DLA valued at $500M through November 2026. The contract requires ultimate...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, with a ceiling value of $20,085.04. The contract calls for the delivery of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials, a long-acting local anesthetic used in surgical and medical settings. The award carries no set-aside designation and is scheduled for ultimate completion...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $10,550.54 firm fixed-price delivery order on May 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the supply of EXPAREL 133 mg/10 ml vials. The award carries an ultimate completion date of June 3, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency valued at $16,071.40 for EXPAREL 266 mg/20 ml vials. The contract, awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,092.20 by the Defense Logistics Agency on September 16, 2025. The delivery order covers EXPAREL 133 mg/10 mL vials (10 mL unit) for delivery by October 7, 2025. This award was issued without set-aside designation, leveraging the company's competitive positioning in federal pharmaceutical procurement. The delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency valued at $4,873.76 for EXPAREL (liposomal bupivacaine) 133 mg/10 mL vials. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $25,106.30 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The award carries an ultimate completion date of June 24, 2025, and does not utilize any set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $7,531.89 with an ultimate completion date of September 2, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- SPE2DB20D9766Indefinite Delivery Contract
- SPE2DB20D9766-SPE2DB25FC1GDDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for EXPAREL 266 mg/20 ml vials valued at $10,042.52. This firm fixed-price delivery order, which has a completion date of September 18, 2025, was issued without a set-aside designation. The award represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management, commonly utilized in surgical and medical settings. The delivery order supports the DLA's mission to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription drugs, biologics, vaccines, and specialty medications to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 8/27/25 |